Skip Navigation

News

  • Apr
    13
    2021

    FDA and CDC announce pause in use of Johnson & Johnson COVID-19 Vaccine

    Posted by: Health and Human Services - COVID Testing

    Update: Monday, April 26, 2021

    On Friday, the FDA announced that it recommends use of the Johnson & Johnson COVID-19 vaccine be resumed. The Oregon Health Authority has cleared providers to begin using the vaccine again as long as patients are provided information warning of the rare but serious risk of blood clots. More information is available from the Oregon Health Authority.

    -------------------------------------

    On Tuesday, April 13, the Centers for Disease Control and Prevention and the Food & Drug Administration announced that use of the Johnson & Johnson COVID-19 vaccine has been paused while they investigate six cases of a severe and rare type of blood clot in women between the ages of 18 and 48.

    Following directives from the Oregon Health Authority, all vaccine providers in Marion County have been notified to pause use of the Johnson & Johnson vaccine. 

    People who have received the J&J vaccine who develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care provider. Health care providers are asked to report adverse events to the Vaccine Adverse Event Reporting System at https://vaers.hhs.gov/reportevent.html.

    Resources:

    As more information becomes available, we will update this post. 


    FDA and CDC announce pause in use of Johnson & Johnson COVID-19 Vaccine
​​​​​ View All News